<p>New York, New York - <a href="https://www.newsfilecorp.com/">Newsfile Corp.</a> - April 15, 2023 - <b>WHY: </b>Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc.</p>
New York, New York - Newsfile Corp. - April 15, 2023 - WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Sarepta.